Experienced in Febrile Neutropenia

Dr. Daniel Dilling

Intensive Care Medicine
Loyola University Medical Center
2160 S 1st Ave, 
Maywood, IL 
Experienced in Febrile Neutropenia
Loyola University Medical Center
2160 S 1st Ave, 
Maywood, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Dilling is an Intensive Care Medicine provider in Maywood, Illinois. Dr. Dilling is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Lymphangioleiomyomatosis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Gastrostomy.

His clinical research consists of co-authoring 50 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in IL
Hospital Affiliations
Loyola University Medical Center
Elmhurst Memorial Hospital
Saint Francis Medical Center
Northwestern Medicine Central Dupage Hospital
Advocate Good Shepherd Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 15 Less Insurance Carriers -

Locations

Loyola University Medical Center
2160 S 1st Ave, Maywood, IL 60153
Call: 708-327-5864
Other Locations
Office
1S260 Summit Ave, Oakbrook Terrace, IL 60181
Call: 630-953-6600

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Suspended
Publish Date: May 30, 2025
Intervention Type: Drug
Study Drug: ORIN1001
Study Phase: Phase 1
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2020
Intervention Type: Drug
Study Phase: Phase 2
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Enrollment Status: Terminated
Publish Date: July 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

50 Total Publications

Are donor-specific antibodies really all that "baseline lung allograft dysfunction"?
Are donor-specific antibodies really all that "baseline lung allograft dysfunction"?
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: June 25, 2025
View All 50 Publications
Similar Doctors
Experienced in Febrile Neutropenia
Dr. Ejaaz Kalimullah
Intensive Care Medicine
Experienced in Febrile Neutropenia
Dr. Ejaaz Kalimullah
Intensive Care Medicine

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (7.2 miles away)
708-216-8785
Languages Spoken:
English
See accepted insurances

Ejaaz Kalimullah is an Intensive Care Medicine provider in Maywood, Illinois. Dr. Kalimullah is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Liver Failure, Febrile Neutropenia, Gastrostomy, and Endoscopy.

Experienced in Febrile Neutropenia
Dr. Elizabeth A. Nakae
Intensive Care Medicine | Pediatrics
Experienced in Febrile Neutropenia
Dr. Elizabeth A. Nakae
Intensive Care Medicine | Pediatrics
1675 Dempster St, Yacktman Pavillion, 
Park Ridge, IL 
 (14.3 miles away)
847-318-9300
Languages Spoken:
English
See accepted insurances

Elizabeth Nakae is an Intensive Care Medicine specialist and a Pediatrics provider in Park Ridge, Illinois. Dr. Nakae is rated as an Experienced provider by MediFind in the treatment of Febrile Neutropenia. Her top areas of expertise are Meckel's Diverticulum, Cerebral Hypoxia, Type 1 Diabetes (T1D), and Respiratory Syncytial Virus (RSV) Infection.

Experienced in Febrile Neutropenia
Dr. Semil Mehta
Intensive Care Medicine
Experienced in Febrile Neutropenia
Dr. Semil Mehta
Intensive Care Medicine

Pulmonary Physicians Of The North Shore LTD

2151 Waukegan Rd Ste 110, 
Bannockburn, IL 
 (22.5 miles away)
847-832-6500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Semil Mehta is an Intensive Care Medicine provider in Bannockburn, Illinois. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Chronic Cough, Obstructive Sleep Apnea, Acute Interstitial Pneumonia, Excessive Daytime Sleepiness, and Fasciotomy.

VIEW MORE FEBRILE NEUTROPENIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dilling's expertise for a condition
ConditionClose
  • Elite
  • Acute Interstitial Pneumonia
    Dr. Dilling is
    Elite
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Idiopathic Pulmonary Fibrosis
    Dr. Dilling is
    Elite
    . Learn about Idiopathic Pulmonary Fibrosis.
    See more Idiopathic Pulmonary Fibrosis experts
  • Interstitial Lung Disease
    Dr. Dilling is
    Elite
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
  • Lymphangioleiomyomatosis
    Dr. Dilling is
    Elite
    . Learn about Lymphangioleiomyomatosis.
    See more Lymphangioleiomyomatosis experts
  • Pulmonary Fibrosis
    Dr. Dilling is
    Elite
    . Learn about Pulmonary Fibrosis.
    See more Pulmonary Fibrosis experts
  • Distinguished
  • Cystic Fibrosis
    Dr. Dilling is
    Distinguished
    . Learn about Cystic Fibrosis.
    See more Cystic Fibrosis experts
  • Hypersensitivity Pneumonitis
    Dr. Dilling is
    Distinguished
    . Learn about Hypersensitivity Pneumonitis.
    See more Hypersensitivity Pneumonitis experts
  • Lung Metastases
    Dr. Dilling is
    Distinguished
    . Learn about Lung Metastases.
    See more Lung Metastases experts
  • Lung Transplant
    Dr. Dilling is
    Distinguished
    . Learn about Lung Transplant.
    See more Lung Transplant experts
  • MAGIC Syndrome
    Dr. Dilling is
    Distinguished
    . Learn about MAGIC Syndrome.
    See more MAGIC Syndrome experts
  • Pneumonia
    Dr. Dilling is
    Distinguished
    . Learn about Pneumonia.
    See more Pneumonia experts
  • Advanced
  • Neurosarcoidosis
    Dr. Dilling is
    Advanced
    . Learn about Neurosarcoidosis.
    See more Neurosarcoidosis experts
  • Newborn Jaundice
    Dr. Dilling is
    Advanced
    . Learn about Newborn Jaundice.
    See more Newborn Jaundice experts
  • Sarcoidosis
    Dr. Dilling is
    Advanced
    . Learn about Sarcoidosis.
    See more Sarcoidosis experts
  • Secondary Immunodeficiency (SID)
    Dr. Dilling is
    Advanced
    . Learn about Secondary Immunodeficiency (SID).
    See more Secondary Immunodeficiency (SID) experts
  • Experienced
  • Alpha-1 Antitrypsin Deficiency (AATD)
    Dr. Dilling is
    Experienced
    . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
    See more Alpha-1 Antitrypsin Deficiency (AATD) experts
  • Birt-Hogg-Dube Syndrome
    Dr. Dilling is
    Experienced
    . Learn about Birt-Hogg-Dube Syndrome.
    See more Birt-Hogg-Dube Syndrome experts
  • Branchiootorenal Syndrome
    Dr. Dilling is
    Experienced
    . Learn about Branchiootorenal Syndrome.
    See more Branchiootorenal Syndrome experts
  • Bronchiectasis
    Dr. Dilling is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Bronchiolitis Obliterans
    Dr. Dilling is
    Experienced
    . Learn about Bronchiolitis Obliterans.
    See more Bronchiolitis Obliterans experts
  • Bronchitis
    Dr. Dilling is
    Experienced
    . Learn about Bronchitis.
    See more Bronchitis experts
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.